Posted by Michael Wonder on 08 Dec 2016
Single drug technology assessment processes across Health Technology Assessment organisations
8 December 2016 - Health Technology Assessment (HTA) informs health care decision-makers about the value — such as the safety, efficacy, and cost-effectiveness — of new and existing health technologies.
HTA can inform clinical decision-making, as well as formulary listing and reimbursement decisions within health care systems. Given the utility of HTA to support evidence-based decision-making, it has been widely adopted and customised across different countries and regions.
